Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

10551	Companies
222919	Keywords
151994	Articles
117952	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 10/01/2024 at 17:11, 1 year 8 months ago

Formycon AG's FYB202 Biosimilar Approved for EU and US Markets

FDA Approval Formycon AG Market Entry Biosimilar Investment Analysis
PRESS RELEASE

published on 10/01/2024 at 17:06, 1 year 8 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH releases an update on Formycon AG, with analyst Simon Scholes reiterating a BUY rating and raising the price target from EUR 80 to EUR 82. The approval of the biosimilar FYB202 in the EU and US contributes to the positive outlook on Formycon's market share prospects

Investment Recommendation Formycon AG First Berlin Equity Research GmbH FYB202 Approval Biosimilar Market
BRIEF

published on 09/30/2024 at 07:35, 1 year 8 months ago

Formycon and Fresenius Kabi Receive FDA Approval for Biosimilar Otulfi

FDA Approval Biosimilar Formycon Fresenius Kabi Otulfi
PRESS RELEASE

published on 09/30/2024 at 07:30, 1 year 8 months ago

Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for FYB202/OtulfiTM (ustekinumab-aauz) to treat several conditions including Crohn’s disease and psoriasis, expanding biosimilar market presence

FDA Approval Biosimilar Formycon Fresenius Kabi Ustekinumab
BRIEF

published on 09/27/2024 at 22:01, 1 year 8 months ago

FDA Grants Approval for Stelara® Biosimilar FYB202/OtulfiTM

FDA Approval Pharmaceutical Formycon AG Biosimilar Stelara®
PRESS RELEASE

published on 09/27/2024 at 21:56, 1 year 8 months ago

EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
FDA grants approval for Stelara Biosimilar FYB202/Otulfi (ustekinumab-aauz) by Formycon AG. Approval based on comprehensive data evaluation. Contact: Sabrina Mueller, Formycon AG

FDA Approval Formycon AG FYB202 Stelara Biosimilar Sabrina Mueller
BRIEF

published on 09/27/2024 at 09:05, 1 year 8 months ago

European Commission Approves Formycon and Fresenius Kabi's Biosimilar FYB202/Otulfi®

European Commission Formycon Fresenius Kabi FYB202 Ustekinumab
PRESS RELEASE

published on 09/27/2024 at 09:00, 1 year 8 months ago

Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
Formycon and Fresenius Kabi secure European Commission approval for FYB202/Otulfi® (ustekinumab) to treat inflammatory diseases, expanding biosimilar portfolio

Biosimilar Formycon Fresenius Kabi Ustekinumab European Commission Approval
BRIEF

published on 09/17/2024 at 06:55, 1 year 8 months ago

Formycon to Present FYB202 Biosimilar Data at EADV Congress and UEG Week

Clinical Data Biosimilar Formycon FYB202 Ustekinumab
PRESS RELEASE

published on 09/17/2024 at 06:50, 1 year 8 months ago

Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna
Formycon to present clinical data on ustekinumab biosimilar FYB202 at EADV Congress in Amsterdam and UEG Week in Vienna. Biosimilar for psoriasis and IBD in final approval phase

Clinical Data Biosimilar Formycon Ustekinumab Approval Process

Accesswire

Published on 06/10/2026 at 14:30, 5 hours 9 minutes ago

Agassi Sports Entertainment Signs Tennis Coaching Icon Darren Cahill to Expand Global Coaching, Content and Technology Initiatives
Published on 06/10/2026 at 14:30, 5 hours 9 minutes ago

Ondas to Launch LADOS, a Layered Autonomous Defense Operational C2 Layer, at Eurosatory 2026
Published on 06/10/2026 at 14:03, 5 hours 36 minutes ago

Shelfie-Tech Announces Private Placement
Published on 06/10/2026 at 13:00, 6 hours 39 minutes ago

Galway Metals Reports 5.0 g/t Gold over 10.85 Metres at North Deposit and Continues to Intersect Gold in Northern Extension
Published on 06/10/2026 at 13:00, 6 hours 39 minutes ago

Jaguar Mining Inc. Accelerates 5-Year Exploration Plan with Tier 1 Drilling Partnerships

View all ACCESSWIRE

EQS Group

Published on 06/10/2026 at 18:39, 59 minutes ago

EQS-Adhoc: Kontron AG: Ad hoc announcement / Ennoconn Corporation intends to launch a mandatory takeover offer to Kontron AG shareholders
Published on 06/10/2026 at 18:20, 1 hour 18 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Hugo Boss AG; Bidder: Frasers Group plc
Published on 06/10/2026 at 18:03, 1 hour 35 minutes ago

Kapsch TrafficCom AG presents preliminary results for 2025/26 and adapts its financial calendar.
Published on 06/10/2026 at 18:00, 1 hour 39 minutes ago

Private Equity Holding AG: Net Asset Value as of May 31, 2026
Published on 06/10/2026 at 17:46, 1 hour 52 minutes ago

FIGEAC AÉRO: 2025/26 FULL-YEAR RESULTS

Les Echos

Published on 06/10/2026 at 18:29, 1 hour 9 minutes ago

ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
Published on 06/10/2026 at 17:59, 1 hour 39 minutes ago

CDA - STGM has received € 127 million
Published on 06/10/2026 at 17:40, 1 hour 59 minutes ago

Report on share repurchases from 3 to 9 June 2026
Published on 06/10/2026 at 07:00, 12 hours 39 minutes ago

Acceleration of Museum Studio's international expansion
Published on 06/09/2026 at 19:30, 1 day ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE